Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Lonza
Sort By
Newest First
Sign in
1 / 3
1 / 3
RNA
What new opportunities are emerging for mRNA technology, and how is the portfolio of applications expanding beyond vaccines?
Pharma's Almanac
PAO-03-25-RT-02
Mar 26, 2025
AI
Is AI truly transforming drug development, or are we still navigating through the hype?
Pharma's Almanac
PAO-02-25-RT-01
Feb 26, 2025
Sustainability
How can pharma manufacturing align with green initiatives while maintaining efficiency and compliance?
Pharma's Almanac
PAO-01-25-RT-02
Jan 31, 2025
Innovation
How is the pharmaceutical industry integrating innovations from adjacent industries to enhance drug development and production?
Pharma's Almanac
PAO-11-24-RT-02
Oct 28, 2024
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01
Aug 07, 2024
Global Access
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Pharma's Almanac
PAO-08-24-RT-02
Aug 07, 2024
Digitalization
How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?
Pharma's Almanac
PAO-06-24-RT-02
Jun 24, 2024
Investment
What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?
Pharma's Almanac
PAO-06-24-RT-01
Jun 24, 2024
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Pharma's Almanac
PAO-03-24-CL-03
Mar 08, 2024
Accelerating Product Development
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Pharma's Almanac
PAO-03-24-CL-02
Mar 08, 2024
CDMO - Small Biotech
Cis-Targeted Immunotherapies Need Large CDMO Expertise But Also Flexibility
Julie Trulson, Ph.D.
PAO-02-24-CL-07
Feb 15, 2024
Tech Transfer
Transparent Communication Supports Tech Transfers Of Cis-targeted Immunotherapies
Julie Trulson, Ph.D.
PAO-02-24-CL-06
Feb 15, 2024
Roundtable
What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?
Pharma's Almanac
PAO-12-23-RT-02
Dec 15, 2023
Roundtable
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?
Pharma's Almanac
PAO-12-23-RT-01
Dec 14, 2023
Real-World Data
How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?
Pharma's Almanac
PAO-09-23-RT-01
Sep 15, 2023
Industry Wisdom
What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?
Pharma's Almanac
PAO-09-23-RT-02
Sep 15, 2023
International Markets
In what international markets do you anticipate significant developments in the near future?
Pharma's Almanac
PAO-01-23-RT-02
Jan 31, 2023
Disruptive Technology
What do you view as the most disruptive or transformational technology or development on the horizon?
Pharma's Almanac
PAO-01-23-RT-01
Jan 31, 2023
Unmet Needs
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?
Pharma's Almanac
PAO-06-022--RT-01
Jun 24, 2022
Industry Challenges
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Pharma's Almanac
O-06-022--RT-01
Jun 24, 2022
